Related Attributes
Product details
Adenosine Raw Material Powder Usage and Synthesis:
Adenosine Powder is an active substance based on nucleoside and purine. It is a nucleoside formed by adenine combined with D-ribose through a β-glycosidic bond. Adenosine Raw Material Powder is widely present in all types of cells. Nucleosides can be either free or compounded in nucleic acids. Adenosine phosphate like ATP is an important energy carrier in biochemical reactions. Adenosine Raw Material Powder is a natural nucleotide, an intermediate product of body metabolism, and one of the important active ingredients in the body. Adenosine is an inhibitory neuromodulator of the central nervous system that signals a balance between the brain's energy stores and energy demands.
Pharmacokinetics of Adenosine Raw Material Powder :
Adenosine has the effect of dilating coronary blood vessels and reducing myocardial contractility. It is clinically applicable to the treatment of angina pectoris, hypertension, cerebrovascular disorders, sequelae of stroke, progressive muscular atrophy, etc. Intravenous injection is used for the treatment of supraventricular tachycardia and 201Tl myocardial imaging.
Clinical Application of Adenosine Raw Material Powder :
1. Adenosine can be used to treat angina pectoris, myocardial infarction, coronary insufficiency, arteriosclerosis, essential hypertension, cerebrovascular disorders, sequelae of stroke, progressive muscle atrophy, etc.
2. Endogenous neurotransmitters. In the pharmaceutical industry, it is mainly used as the main raw material for the manufacture of adenosine vidarabine (Ara-AR), adenosine triphosphate (ATP), coenzyme A (COASH) and its series product cyclic adenosine monophosphate (CAMP).
3. Adenosine induces apoptosis of human leukemia HL-60 cells. It also has antiarrhythmic properties. A neurotransmitter that acts as the preferred endogenous agonist at all subtypes of adenosine A receptors.
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2022 Xi'an Henrikang Biotech Co., Ltd.,